MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/16078454.2021.1929694

Медицинская библиотека · Hematology (Amsterdam, Netherlands) · 2021

Low- and intermediate-risk myelodysplastic syndrome with pure red cell aplasia.

Wang Huaquan, Niu Haiyue, Zhang Tian, Xing Limin, Shao Zonghong, Fu Rong

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

Our aim is to investigate the clinical characteristics of low- and intermediate-risk myelodysplastic syndrome (MDS) with pure red cell aplasia (PRCA).

METHODS

We retrospectively reviewed the patients of low- and intermediate-risk MDS patients who had been diagnosed with PRCA in our hospital between January 2010 and December 2019.

RESULTS

There were 6 low- and intermediate-risk MDS patients with PRCA in our study, 1 male and 5 females, with a median age of 63.5 (50-75) years. It accounted for 7.7% (6/78) of all diagnosed PRCA cases and 1.67% (6/359) of diagnosed MDS cases during the same period. All patients were treated with multiple drugs, including recombinant human erythropoietin, cyclosporine, glucocorticoids, androgen, sirolimus, intravenous immunoglobulin and decitabine. Two patients achieved complete remission, two patients achieved partial remission and became blood transfusion independent. Two patients had no response and one patient died.

CONCLUSION

Low- and intermediate-risk MDS with PRCA was difficult to treat, but the prognosis was good.

Для цитирования: Wang Huaquan, Niu Haiyue, Zhang Tian, Xing Limin, Shao Zonghong, Fu Rong. Low- and intermediate-risk myelodysplastic syndrome with pure red cell aplasia.. Hematology (Amsterdam, Netherlands). 2021. DOI: 10.1080/16078454.2021.1929694.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.